Boothbay Fund Management’s Moderna MRNA Stock Holding History

Boothbay Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,900	Closed	-$462K	–	2217
2025 Q3	$462K	Buy	+17,900	New	+$499K	0.01%	1216
2025 Q2	–	Sell	-100,000	Closed	-$2.83M	–	1668
2025 Q1	$2.83M	Buy	+100,000	New	+$3.55M	0.07%	353
2023 Q1	–	Sell	-35,600	Closed	-$6.39M	–	2380
2022 Q4	$6.39M	Buy	+35,600	New	+$5.82M	0.15%	146
2021 Q2	–	Sell	-117	Closed	-$1.53M	–	2013
2021 Q1	$1.53M	Buy	+117	New	+$17K	0.06%	419
2020 Q3	–	Sell	-38	Closed	-$244K	–	1143
2020 Q2	$244K	Buy	+38	New	+$2.08K	0.02%	757

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's MRNA Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Moderna (MRNA) in Q1 2026: 7,772 shares worth $395K. The stake represents 0.01% of the portfolio and ranks #1476 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in MRNA as recently as Q3 2025.

Boothbay Fund Management first reported a position in MRNA in Q4 2018 and has held it in 11 quarters since. The position peaked at $925K in Q4 2020. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Boothbay Fund Management held 7,772 shares of Moderna worth $395K as of Q1 2026.
Moderna was a new Boothbay Fund Management position in Q1 2026.
Moderna made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1476 holding.
Boothbay Fund Management first reported a position in Moderna in Q4 2018 and has held it in 11 quarters since.
Boothbay Fund Management's Moderna position peaked at $925K in Q4 2020.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.